Skip to main content

Table 2 Comorbidities and traditional risk factors for cardiovascular diseases

From: Increased modifiable cardiovascular risk factors in patients with Takayasu arteritis: a multicenter cross-sectional study

  TAK (n=20) CTR (n=16) P value
SAH or drug treatment 16 (80)
Dyslipidemia or drug treatment 11 (55)
Type 2 diabetes mellitus or drug treatment 2 (10)
Smoker
Total cholesterol (mg/dL) 167.0 (143.5–188.5) 177.0 (148.0–208.0) 0.335
HDL-cholesterol (mg/dL) 60.0 (48.5–74.0) 50.0 (48.0–81.0) 0.899
LDL-cholesterol (mg/dL) 93.0 (78.5–107.0) 109.0 (109.0–120.0) 0.089
Triglycerides (mg/dL) 100.0 (74.5–114.5) 83.0 (53.0–87.0) 0.279
Fasting glucose test (mg/dL) 83.5 (80.25–92.0) 85.0 (81.0–89.0) 0.832
  1. Data are presented as median (25–75%) or percentage (%)
  2. CTR Control group, SAH Systemic arterial hypertension, TAK Takayasu arteritis